Page last updated: 2024-10-26

eprazinone and Lung Diseases, Obstructive

eprazinone has been researched along with Lung Diseases, Obstructive in 1 studies

eprazinone : A member of the class of piperazines in which the two amino hydrogens of piperazine are replaced by 2-benzoylpropyl and 2-ethoxy-2-phenylethyl groups.

Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bury, T1
Corhay, JL1
Radermecker, MF1

Other Studies

1 other study available for eprazinone and Lung Diseases, Obstructive

ArticleYear
[Kinetics of mucus].
    Revue medicale de Liege, 1990, Jan-01, Volume: 45, Issue:1

    Topics: Acetylcysteine; Antitussive Agents; Bromhexine; Cough; Expectorants; Humans; Lung Diseases, Obstruct

1990